Author:
Merz Erin L.,Malcarne Vanessa L.,Roesch Scott C.,Nair Deepthi K.,Salazar Gloria,Assassi Shervin,Mayes Maureen D.
Funder
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference44 articles.
1. Medsger, T. A. (2003). Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheumatic Disease Clinics of North America,
29(2), 255–273.
2. LeRoy, E. C., Black, C., Fleischmajer, R., Jablonska, S., Krieg, T., Medsger, T. A., et al. (1988). Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. The Journal of Rheumatology,
15(2), 202–205.
3. Patterson, K. A., Roberts-Thomson, P. J., Lester, S., Tan, J. A., Hakendorf, P., Rischmueller, M., et al. (2015). Interpretation of an extended autoantibody profile in a well-characterized Australian systemic sclerosis (scleroderma) cohort using principal components analysis. Arthritis and Rheumatology,
67(12), 3234–3244.
4. Benrud-Larson, L. M., Haythornthwaite, J. A., Heinberg, L. J., Boling, C., Reed, J., White, B., et al. (2002). The impact of pain and symptoms of depression in scleroderma. Pain,
95(3), 267–275.
5. Carreira, P. E. (2006). “Quality of pain” in systemic sclerosis. Rheumatology,
45(10), 1185–1186.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献